| Publication |
Sentence |
Publish Date |
Extraction Date |
Species |
| Loren Tapp, Jessica G Ramsey, Anita Wen, Roy Geron. Synthetic Cannabinoid and Mitragynine Exposure of Law Enforcement Agents During the Raid of an Illegal Laboratory - Nevada, 2014. MMWR. Morbidity and mortality weekly report. vol 66. issue 47. 2017-12-05. PMID:29190268. |
synthetic cannabinoids (scs), commonly known by the street name "spice," are designer drugs of abuse that mimic the psychoactive effects of marijuana. |
2017-12-05 |
2023-08-13 |
Not clear |
| Valentina Lorenzetti, Silvia Alonso-Lana, George J Youssef, Antonio Verdejo-Garcia, Chao Suo, Janna Cousijn, Michael Takagi, Murat Yücel, Nadia Solowi. Adolescent Cannabis Use: What is the Evidence for Functional Brain Alteration? Current pharmaceutical design. vol 22. issue 42. 2017-12-04. PMID:27514709. |
cannabis use typically commences during adolescence, a period during which the brain undergoes profound remodeling in areas that are high in cannabinoid receptors and that mediate cognitive control and emotion regulation. |
2017-12-04 |
2023-08-13 |
Not clear |
| Aviv Weinstein, Abigail Livny, Abraham Weizma. Brain Imaging Studies on the Cognitive, Pharmacological and Neurobiological Effects of Cannabis in Humans: Evidence from Studies of Adult Users. Current pharmaceutical design. vol 22. issue 42. 2017-12-04. PMID:27549374. |
brain imaging studies using selective high-affinity radioligands for the imaging of cannabinoid cb1 receptor availability in positron emission tomography (pet) showed downregulation of cb1 in regular users of cannabis. |
2017-12-04 |
2023-08-13 |
human |
| Deepak Cyril D'Souza, Rajiv Radhakrishnan, Mohamed Sherif, Jose Cortes-Briones, John Cahill, Swapnil Gupta, Patrick D Skosnik, Mohini Ranganatha. Cannabinoids and Psychosis. Current pharmaceutical design. vol 22. issue 42. 2017-12-04. PMID:27568729. |
experimental studies reveal that cannabis, tetrahydrocannabinol (thc) and synthetic cannabinoids reliably produce transient positive, negative, and cognitive symptoms in healthy volunteers. |
2017-12-04 |
2023-08-13 |
human |
| Laurent Karila, Amine Benyamina, Lisa Blecha, Olivier Cottencin, Joël Billieu. The Synthetic Cannabinoids Phenomenon. Current pharmaceutical design. vol 22. issue 42. 2017-12-04. PMID:27655416. |
the emergence of smokable herbal products containing synthetic cannabinoids, which mimic the effects of cannabis, appears to become increasingly popular, in the new psychoactive substances landscape. |
2017-12-04 |
2023-08-13 |
Not clear |
| Laurent Karila, Amine Benyamina, Lisa Blecha, Olivier Cottencin, Joël Billieu. The Synthetic Cannabinoids Phenomenon. Current pharmaceutical design. vol 22. issue 42. 2017-12-04. PMID:27655416. |
the majority of the synthetic cannabinoids are full agonists at the cb1 receptor and do not contain tobacco or cannabis. |
2017-12-04 |
2023-08-13 |
Not clear |
| Luara A Batista, Andrea S Haibara, Luiz C Schenberg, Fabricio A Moreir. Effects of alprazolam and cannabinoid-related compounds in an animal model of panic attack. Behavioural brain research. vol 317. 2017-12-04. PMID:27737792. |
urb597 (0.1, 0.3, 1mg/kg; inhibitor of anandamide hydrolysis), win55,212-2 (0.1, 0.3, 1mg/kg; synthetic cannabinoid), arachidonoyl-serotonin (1, 2.5, 5mg/kg; dual trpv1 and anandamide hydrolysis inhibitor), and cannabidiol (5, 10, 20, 40mg/kg; a phytocannabinoid) did not decrease escape duration. |
2017-12-04 |
2023-08-13 |
rat |
| Cecilia J Sorensen, Kristen DeSanto, Laura Borgelt, Kristina T Phillips, Andrew A Mont. Cannabinoid Hyperemesis Syndrome: Diagnosis, Pathophysiology, and Treatment-a Systematic Review. Journal of medical toxicology : official journal of the American College of Medical Toxicology. vol 13. issue 1. 2017-12-01. PMID:28000146. |
cannabinoid hyperemesis syndrome (chs) is a syndrome of cyclic vomiting associated with cannabis use. |
2017-12-01 |
2023-08-13 |
Not clear |
| K Cohen, M Kapitány-Fövény, Y Mama, M Arieli, P Rosca, Z Demetrovics, A Weinstei. The effects of synthetic cannabinoids on executive function. Psychopharmacology. vol 234. issue 7. 2017-12-01. PMID:28160034. |
synthetic cannabinoid products have effects similar to those of natural cannabis but the new synthetic cannabinoids are more potent and dangerous and their use has resulted in various adverse effects. |
2017-12-01 |
2023-08-13 |
Not clear |
| Kayla A Chase, Benjamin Feiner, Cherise Rosen, David P Gavin, Rajiv P Sharm. Characterization of peripheral cannabinoid receptor expression and clinical correlates in schizophrenia. Psychiatry research. vol 245. 2017-11-28. PMID:27591408. |
these results continue to support dysregulation of particular aspects of the endocannabinoid signaling system in participants with schizophrenia selected for the self-reported absence of marijuana abuse/dependence. |
2017-11-28 |
2023-08-13 |
human |
| Thangavelu Soundara Rajan, Sabrina Giacoppo, Domenico Scionti, Francesca Diomede, Gianpaolo Grassi, Federica Pollastro, Adriano Piattelli, Placido Bramanti, Emanuela Mazzon, Oriana Trubian. Cannabidiol Activates Neuronal Precursor Genes in Human Gingival Mesenchymal Stromal Cells. Journal of cellular biochemistry. vol 118. issue 6. 2017-11-28. PMID:27918106. |
this study was aimed to investigate whether in vitro pre-treatment of mscs obtained from human gingiva (hgmscs) with cannabidiol (cbd), a cannabinoid component produced by the plant cannabis sativa, may promote human gingiva derived mscs to differentiate toward neuronal precursor cells. |
2017-11-28 |
2023-08-13 |
human |
| Will Lawn, Tom P Freeman, Rebecca A Pope, Alyssa Joye, Lisa Harvey, Chandni Hindocha, Claire Mokrysz, Abigail Moss, Matthew B Wall, Michael Ap Bloomfield, Ravi K Das, Celia Ja Morgan, David J Nutt, H Valerie Curra. Acute and chronic effects of cannabinoids on effort-related decision-making and reward learning: an evaluation of the cannabis 'amotivational' hypotheses. Psychopharmacology. vol 233. issue 19-20. 2017-11-24. PMID:27585792. |
acute and chronic effects of cannabinoids on effort-related decision-making and reward learning: an evaluation of the cannabis 'amotivational' hypotheses. |
2017-11-24 |
2023-08-13 |
Not clear |
| Szilvia Kassai, Judit Nóra Pintér, József Rácz, Brigitta Böröndi, Tamás Tóth-Karikó, Kitti Kerekes, V Anna Gyarmath. Assessing the experience of using synthetic cannabinoids by means of interpretative phenomenological analysis. Harm reduction journal. vol 14. issue 1. 2017-11-22. PMID:28187774. |
one of the largest groups of nps is synthetic cannabinoids (scs), which are intended as a replacement to cannabis. |
2017-11-22 |
2023-08-13 |
Not clear |
| Hemant Lata, Suman Chandra, Ikhlas A Khan, Mahmoud A ElSohl. In Vitro Propagation of Cannabis sativa L. and Evaluation of Regenerated Plants for Genetic Fidelity and Cannabinoids Content for Quality Assurance. Methods in molecular biology (Clifton, N.J.). vol 1391. 2017-11-21. PMID:27108324. |
in vitro propagation of cannabis sativa l. and evaluation of regenerated plants for genetic fidelity and cannabinoids content for quality assurance. |
2017-11-21 |
2023-08-13 |
Not clear |
| Håvard T Garberg, Marianne U Huun, Javier Escobar, Jose Martinez-Orgado, Else-Marit Løberg, Rønnaug Solberg, Ola Didrik Saugsta. Short-term effects of cannabidiol after global hypoxia-ischemia in newborn piglets. Pediatric research. vol 80. issue 5. 2017-11-16. PMID:27441365. |
cannabidiol (cbd), a nonpsychoactive cannabinoid, has shown neuroprotective actions after neonatal hypoxia-ischemia (hi) in animals. |
2017-11-16 |
2023-08-13 |
Not clear |
| Nora D Volkow, Aidan J Hampson, Ruben D Bale. Don't Worry, Be Happy: Endocannabinoids and Cannabis at the Intersection of Stress and Reward. Annual review of pharmacology and toxicology. vol 57. 2017-11-16. PMID:27618739. |
cannabis enables and enhances the subjective sense of well-being by stimulating the endocannabinoid system (ecs), which plays a key role in modulating the response to stress, reward, and their interactions. |
2017-11-16 |
2023-08-13 |
Not clear |
| Cecilia J Hillard, Margaret Beatka, Jenna Sarvaide. Endocannabinoid Signaling and the Hypothalamic-Pituitary-Adrenal Axis. Comprehensive Physiology. vol 7. issue 1. 2017-11-16. PMID:28134998. |
the elucidation of Δ9-tetrahydrocannabinol as the active principal of cannabis sativa in 1963 initiated a fruitful half-century of scientific discovery, culminating in the identification of the endocannabinoid signaling system, a previously unknown neuromodulatory system. |
2017-11-16 |
2023-08-13 |
Not clear |
| Shane Shucheng Wong, Timothy E Wilen. Medical Cannabinoids in Children and Adolescents: A Systematic Review. Pediatrics. vol 140. issue 5. 2017-11-13. PMID:29061872. |
legalization of medical marijuana in many states has led to a widening gap between the accessibility and the evidence for cannabinoids as a medical treatment. |
2017-11-13 |
2023-08-13 |
Not clear |
| Amélie Marsot, Christine Audebert, Laurence Attolini, Bruno Lacarelle, Joelle Micallef, Olivier Bli. Comparison of Cannabinoid Concentrations in Plasma, Oral Fluid and Urine in Occasional Cannabis Smokers After Smoking Cannabis Cigarette. Journal of pharmacy & pharmaceutical sciences : a publication of the Canadian Society for Pharmaceutical Sciences, Societe canadienne des sciences pharmaceutiques. vol 19. issue 3. 2017-11-10. PMID:27806250. |
comparison of cannabinoid concentrations in plasma, oral fluid and urine in occasional cannabis smokers after smoking cannabis cigarette. |
2017-11-10 |
2023-08-13 |
Not clear |
| Daniel G Couch, Chris Tasker, Elena Theophilidou, Jonathan N Lund, Saoirse E O'Sulliva. Cannabidiol and palmitoylethanolamide are anti-inflammatory in the acutely inflamed human colon. Clinical science (London, England : 1979). vol 131. issue 21. 2017-11-09. PMID:28954820. |
we sought to quantify the anti-inflammatory effects of two cannabinoid drugs, cannabidiol (cbd) and palmitoylethanolamide (pea), in cultured cell lines and compared this effect with experimentally inflamed explant human colonic tissue. |
2017-11-09 |
2023-08-13 |
human |